So-Young International Inc - ADR

So-Young International, Inc. engages in discovering, evaluating and reserving medical aesthetic services. Its business model comprises of three components: Content and its distribution through major social media networks and targeted media platforms in China; Social community characterized by signature user-generated content and; Online reservation services for medical aesthetic treatment. The company was founded by Jin Xing and Yu Tao in March 2013 and is headquartered in Beijing, China.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

So-Young International Inc surpasses revenue targets and expands clinic network

So-Young International Inc delivered strong financial performance in Q1 2024, exceeding revenue guidance and achieving profitability milestones.
The company's strategic focus on expanding clinics, launching successful products, and addressing industry challenges positions it for future growth.
While facing challenges in maintaining growth rates and operational efficiency, So-Young International Inc has opportunities to capitalize on market trends and optimize its cost structure.

So-Young International Inc exceeds Q2 revenue targets, eyes clinic franchise

So-Young International Inc delivered impressive Q2 results, showcasing revenue growth, profit increase, and strong customer engagement across key segments.
The company's focus on expanding So-Young Prime and franchising clinics presents growth avenues, while product innovation drives competitiveness in the market.
Challenges lie in managing operational complexities, optimizing margins, and sustaining growth amidst industry competition and changing consumer trends.

So-Young International Inc exceeds Q3 revenue targets, eyes expansion opportunities

So-Young International Inc delivered strong financial performance in Q3, surpassing revenue targets and achieving notable profit growth.
The company's focus on customer satisfaction, cost efficiency, and business diversification positions it well for future success.
While facing challenges in expansion and market competition, strategic planning and leveraging growth opportunities can drive sustained success.
Overall, So-Young's Q3 performance highlights its resilience and potential for continued growth in the healthcare sector.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

So-Young International, Inc. engages in the operation of a medical aesthetic service platform. It focuses on content and its distribution through major social media networks and targeted media platforms in China, social community characterized by signature user-generated content, and online reservation services for medical aesthetic treatment. The company was founded by Xing Jin and Tao Yu in March 2013 and is headquartered in Beijing, China.

BEIJING , Nov. 20, 2024 /PRNewswire/ -- So-Young International Inc. (Nasdaq: SY) ("So-Young" or the "Company"), the largest and most vibrant social community in China for consumers, professionals and service providers in the medical aesthetics industry, today announced its unaudited financial results for the third quarter ended September 30, 2024. Third Quarter 202 4 Financial Highlights Total revenues were RMB371.8 million (US$53.0 million [1] ), compared with RMB385.3 million in the corresponding period of 2023, exceeding the high end of guidance.

So-Young Reports Unaudited Third Quarter 2024 Financial Results

BEIJING , Nov. 6, 2024 /PRNewswire/ -- So-Young International Inc. (NASDAQ: SY) ("So-Young" or the "Company"), the largest and most vibrant social community in China for consumers, professionals and service providers in the medical aesthetics industry, today announced that it will report its financial results for the third quarter ended September 30, 2024, before U.S. markets open on November 20, 2024. So-Young's management will hold an earnings conference call on Wednesday, November 20, 2024, at 7:00 AM U.S. Eastern Time (8:00 PM on the same day, Beijing/Hong Kong Time).

So-Young to Report Third Quarter 2024 Financial Results on November 20, 2024

BEIJING , Aug. 29, 2024 /PRNewswire/ -- So-Young International Inc. (Nasdaq: SY) ("So-Young" or the "Company"), the largest and most vibrant social community in China for consumers, professionals and service providers in the medical aesthetics industry, today announced it has received a notification letter dated August 28, 2024 (the "Notice") from the staff of the Listing Qualifications Department of The Nasdaq Stock Market LLC ("Nasdaq"), indicating that for the last 30 consecutive business days, the closing bid price of the Company's American depositary shares (the "ADSs") was below the minimum bid price of US$1.00 per share requirement set forth in Nasdaq Listing Rule 5450(a)(1). The Notice has no current effect on the listing or trading of the Company's ADSs on Nasdaq.

So-Young Announces Receipt of Minimum Bid Price Notice from Nasdaq

So-Young International Inc. (NASDAQ:SY ) Q2 2024 Earnings Conference Call August 23, 2024 7:30 AM ET Company Participants Mona Qiao - IR Xing Jin - Co-Founder, Director and CEO Hui Zhao - CFO Conference Call Participants Chloe Wei - CICC Nelson Cheung - Citibank Ivy Lian - Haitong Securities Operator Ladies and gentlemen, thank you for standing by for So-Young's Second Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode.

So-Young International Inc. (SY) Q2 2024 Earnings Call Transcript

BEIJING , Aug. 23, 2024 /PRNewswire/ -- So-Young International Inc. (Nasdaq: SY) ("So-Young" or the "Company"), the largest and most vibrant social community in China for consumers, professionals and service providers in the medical aesthetics industry, today announced its unaudited financial results for the second quarter ended June 30, 2024. Second Quarter 202 4 Financial Highlights Total revenues were RMB407.4 million (US$56.1 million [1]), compared with RMB412.1 million in the corresponding period of 2023, exceeding the high end of guidance.

So-Young Reports Unaudited Second Quarter 2024 Financial Results

BEIJING, Aug. 5, 2024 /PRNewswire/ -- So-Young International Inc. (NASDAQ: SY) ("So-Young" or the "Company"), the largest and most vibrant social community in China for consumers, professionals and service providers in the medical aesthetics industry, today announced that it will report its financial results for the second quarter ended June 30, 2024, before U.S. markets open on August 23, 2024. So-Young's management will hold an earnings conference call on Friday, August 23, 2024, at 7:30 AM U.S. Eastern Time (7:30 PM on the same day, Beijing/Hong Kong Time).

So-Young to Report Second Quarter 2024 Financial Results on August 23, 2024

So-Young International Inc. (NASDAQ:SY ) Q1 2024 Earnings Conference Call May 28, 2024 7:30 AM ET Company Participants Mona Qiao - Investor Relations Xing Jin - Co-Founder, Director and Chief Executive Officer Hui Zhao - Chief Financial Officer Conference Call Participants Chloe Wei - CICC Yibing Wang - Haitong Joey Chan - Jefferies Operator Ladies and gentlemen, thank you for standing by for So-Young's First Quarter 2024 Earnings Conference Call. At this time all participants' are in listen-only mode.

So-Young International Inc. (SY) Q1 2024 Earnings Call Transcript

BEIJING , May 28, 2024 /PRNewswire/ -- So-Young International Inc. (Nasdaq: SY) ("So-Young" or the "Company"), the largest and most vibrant social community in China for consumers, professionals and service providers in the medical aesthetics industry, today announced its unaudited financial results for the first quarter ended March 31, 2024. First Quarter 202 4 Financial Highlights Total revenues were RMB318.3 million (US$44.1 million [1] ), compared with RMB310.1 million in the corresponding period of 2023, exceeding the high end of guidance.

So-Young Reports Unaudited First Quarter 2024 Financial Results

BEIJING , May 21, 2024 /PRNewswire/ -- So-Young International Inc. (NASDAQ: SY) ("So-Young" or the "Company"), the largest and most vibrant social community in China for consumers, professionals and service providers in the medical aesthetics industry, today announced that it will report its financial results for the first quarter ended March 31, 2024, before U.S. markets open on May 28, 2024. So-Young's management will hold an earnings conference call on Tuesday, May 28, 2024, at 7:30 AM U.S. Eastern Time (7:30 PM on the same day, Beijing/Hong Kong Time).

So-Young to Report First Quarter 2024 Financial Results on May 28, 2024

BEIJING , April 25, 2024 /PRNewswire/ -- So-Young International Inc. (Nasdaq: SY) ("So-Young" or the "Company"), the largest and most vibrant social community in China for consumers, professionals and service providers in the medical aesthetics industry, today announced that it filed its annual report on Form 20-F for the fiscal year ended December 31, 2023 with the Securities and Exchange Commission on April 25, 2024. The annual report is available on the Company's investor relations website at http://ir.soyoung.com.

So-Young International Inc. Files Its Annual Report on Form 20-F

So-Young International Inc. (SY) Q4 2023 Earnings Call Transcript

BEIJING, March 20, 2024 /PRNewswire/ -- So-Young International Inc. (Nasdaq: SY) ("So-Young" or the "Company"), the largest and most vibrant social community in China for consumers, professionals and service providers in the medical aesthetics industry, today announced its unaudited financial results for the fourth quarter and fiscal year ended December 31, 2023. Fourth Quarter 202 3 Financial Highlights Total revenues were RMB390.6 million (US$55.0 million [1] ), compared with RMB325.1 million in the corresponding period of 2022, in line with previous guidance.

So-Young Reports Unaudited Fourth Quarter and Fiscal Year 2023 Financial Results

BEIJING , March 14, 2024 /PRNewswire/ -- So-Young International Inc. (NASDAQ: SY) ("So-Young" or the "Company"), the largest and most vibrant social community in China for consumers, professionals and service providers in the medical aesthetics industry, today announced that it will report its financial results for the fourth quarter and full year ended December 31, 2023, before U.S. markets open on March 20, 2024. So-Young's management will hold an earnings conference call on Wednesday, March 20 , 2024, at 7:30 AM U.S. Eastern Time (7:30 PM on the same day, Beijing/Hong Kong Time).

So-Young to Report Fourth Quarter and Full Year 2023 Financial Results on March 20, 2024

BEIJING, Jan. 8, 2024 /PRNewswire/ -- So-Young International Inc. (NASDAQ: SY) ("So-Young" or the "Company"), the largest and most vibrant social community in China for consumers, professionals and service providers in the medical aesthetics industry, today announced that during the term of the Company's share repurchase program previously announced in November 2022 and modified in January 2023 (the "2022 Share Repurchase Program") and the share repurchase program previously announced in May 2021 (the "2021 Share Repurchase Program"), the Company in aggregate purchased approximately 13.3 million ADSs, representing 10.3 million Class A ordinary shares of the Company, for an aggregate consideration of approximately US$54.5 million (inclusive of broker commissions). The Company plans to cancel all of the Class A ordinary shares underlying the ADSs that were repurchased under the 2022 Share Repurchase Program and the 2021 Share Repurchase Program.

So-Young Announces Update on Repurchase and Cancellation of Shares

BEIJING , Jan. 5, 2024 /PRNewswire/ -- So-Young International Inc. (NASDAQ: SY) ("So-Young" or the "Company"), the largest and most vibrant social community in China for consumers, professionals and service providers in the medical aesthetics industry, today announced that the Compensation Committee has approved to grant, and the Company has granted to Mr. Xing Jin, the chairman of the board of directors and the chief executive officer of the Company, 2,923,077 restricted share units of the Company (the "Restricted Share Units"), each representing the right to receive one Class A ordinary share of the Company upon vesting.

Grant of Restricted Share Units to Mr. Xing Jin

BEIJING , Dec. 1, 2023 /PRNewswire/ -- So-Young International Inc. (NASDAQ: SY) ("So-Young" or the "Company"), the largest and most vibrant social community in China for consumers, professionals and service providers in the medical aesthetics industry, today announced that it has entered into a strategic partnership with Healtech, a fully-integrated contract research organization (CRO) and contract manufacturing organization (CMO) for the pharmaceutical industry in China, to jointly develop two regenerative medical aesthetic products and further expand its supply chain business. The strategic partnership marks another important milestone as So-Young expands further upstream along the medical aesthetic supply chain to develop deeper synergies with its existing business and fully leverage its institutional network and expansive consumer reach.

So-Young Enters into Strategic Partnership with Healtech to Further Expand Supply Chain Business

So-Young International Inc. (NASDAQ:SY ) Q3 2023 Earnings Call Transcript November 20, 2023 7:00 AM ET Company Participants Vivian Xu - IR Xing Jin - Co-Founder, Chairman and CEO Hui Zhao - CFO Conference Call Participants Thomas Chong - Jefferies Nelson Cheung - Citi Chloe Wei - CICC Operator Ladies and gentlemen, thank you for standing by for So-Young's Third Quarter 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode.

So-Young International Inc. (SY) Q3 2023 Earnings Call Transcript

BEIJING , Nov. 20, 2023 /PRNewswire/ -- So-Young International Inc. (Nasdaq: SY) ("So-Young" or the "Company"), the largest and most vibrant social community in China for consumers, professionals and service providers in the medical aesthetics industry, today announced its unaudited financial results for the third quarter ended September 30, 2023. Third Quarter 202 3 Financial Highlights Total revenues were RMB385.3 million (US$52.8 million [1] ), an increase of 19.2% from RMB323.3 million in the same period of 2022, in line with previous guidance.

So-Young Reports Unaudited Third Quarter 2023 Financial Results

BEIJING , Nov. 13, 2023 /PRNewswire/ -- So-Young International Inc. (Nasdaq: SY) ("So-Young" or the "Company"), the largest and most vibrant social community in China for consumers, professionals and service providers in the medical aesthetics industry, today announced that its subsidiary Miracle Laser Systems, Inc. ("Wuhan Miracle") recently has submitted the application documents for its potential initial public offering ("IPO") and listing on the Beijing Stock Exchange. The IPO application documents have been received and under reviewed by the Beijing Stock Exchange.

So-Young's Subsidiary Wuhan Miracle Submits Application Documents for Initial Public Offering on China's Beijing Stock Exchange

BEIJING , Nov. 10, 2023 /PRNewswire/ -- So-Young International Inc. (NASDAQ: SY) ("So-Young" or the "Company"), the largest and most vibrant social community in China for consumers, professionals and service providers in the medical aesthetics industry, today announced that it will report its financial results for the third quarter ended September 30, 2023, before U.S. markets open on November 20, 2023. So-Young's management will hold an earnings conference call on Monday, November 20, 2023, at 7:00 AM U.S. Eastern Time (8:00 PM on the same day, Beijing/Hong Kong Time).

So-Young to Report Third Quarter 2023 Financial Results on November 20, 2023

GSX Techedu Inc.

BEIJING , Oct. 12, 2023 /PRNewswire/ -- So-Young International Inc. (Nasdaq: SY) ("So-Young" or the "Company"), the largest and most vibrant social community in China for consumers, professionals and service providers in the medical aesthetics industry, today announced that Mr. Min Yu, Mr.

So-Young Announces Board Change

So-Young International Inc. (NASDAQ:SY ) Q2 2023 Earnings Conference Call August 21, 2023 7:30 AM ET Company Participants Vivian XU - IR Xing Jin - Co-Founder, Chairman and CEO Hui Zhao - CFO Conference Call Participants Thomas Chong - Jefferies Chloe Wei - CICC Operator Ladies and gentlemen, thank you for standing by for So-Young's Second Quarter 2023 Earnings Conference Call. [Operator Instructions] As a reminder, today's conference call is being recorded.

So-Young International Inc. (SY) Q2 2023 Earnings Call Transcript

BEIJING , Aug. 21, 2023 /PRNewswire/ -- So-Young International Inc. (Nasdaq: SY) ("So-Young" or the "Company"), the largest and most vibrant social community in China for consumers, professionals and service providers in the medical aesthetics industry, today announced its unaudited financial results for the second quarter ended June 30, 2023. Second Quarter 202 3 Financial Highlights Total revenues were RMB412.1 million (US$56.8 million [1] ), an increase of 33.3% from RMB309.1 million in the same period of 2022, exceeding the high end of guidance.

So-Young Reports Unaudited Second Quarter 2023 Financial Results

BEIJING , Aug. 15, 2023 /PRNewswire/ -- So-Young International Inc. (NASDAQ: SY) ("So-Young" or the "Company"), the largest and most vibrant social community in China for consumers, professionals and service providers in the medical aesthetics industry, today announced that it will report its financial results for the second quarter ended June 30, 2023, before U.S. markets open on August 21, 2023 . So-Young's management will hold an earnings conference call on Monday, August 21, 2023, at 7:30 AM U.S. Eastern Time (7:30 PM on the same day, Beijing/Hong Kong Time).

So-Young to Report Second Quarter 2023 Financial Results on August 21, 2023

So-Young stands to benefit from strong growth in China's medical aesthetic market. Recent financial and operating results from the company have disappointed, highlighting ongoing uncertainties. We expect shares to remain volatile.

News for So-Young International Inc - ADR Stock (SY)